Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...
Average recurrence intervals are a way of explaining how rare an event is, by comparing how often, on average, the particular event of interest has occurred in the past - more than once a year, more ...
BMI's Relation to Cancer Therapy Mortality Risks ... The platform uses new algorithms developed by the team and enables fully automated analysis of tissue ... July 17, 2024 — A medication ...
We use cookies in order to ensure that you can get the best browsing experience possible on the Council website. Certain cookies are used to obtain aggregated statistics about website visits to help ...